Details for New Drug Application (NDA): 018771
✉ Email this page to a colleague
NDA 018771 describes LACRISERT, which is a drug marketed by Bausch And Lomb Inc and is included in one NDA. Additional details are available on the LACRISERT profile page.
The generic ingredient in LACRISERT is hydroxypropyl cellulose. There are forty-one drug master file entries for this compound. Additional details are available on the hydroxypropyl cellulose profile page.
The generic ingredient in LACRISERT is hydroxypropyl cellulose. There are forty-one drug master file entries for this compound. Additional details are available on the hydroxypropyl cellulose profile page.
Summary for 018771
| Tradename: | LACRISERT |
| Applicant: | Bausch And Lomb Inc |
| Ingredient: | hydroxypropyl cellulose |
| Patents: | 0 |
Pharmacology for NDA: 018771
| Mechanism of Action | Demulcent Activity |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INSERT;OPHTHALMIC | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
